Professor Hans-J. Woerle

• Germany
• Healthcare
• Pharma & Biotech
• Science

Boehringer Ingelheim: Phase III clinical trial found that empagliflozin in combination with metformin reduces blood glucose levels in adults with type 2 diabetes

Initial combinations of empagliflozin and metformin in patients with T2D led to significant reductions in blood glucose vs. empagliflozin or…